Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lopez

Showing results (761-770 of 785) with videos related to

Pageof 79
Sort By:
Cancer Discovery|September 22, 2020
Triplet Therapy with Palbociclib, Taselisib, and Fulvestrant in <i>PIK3CA</i>-Mutant Breast Cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid CancersJavier Pascual, Joline S J Lim, Iain R Macpherson, et al.
Nature|January 22, 2025
Regional and institutional trends in assessment for academic promotionB H Lim, C D'Ippoliti, M Dominik, et al.
ISRN Dentistry|July 7, 2011
Detection of Streptococcus mutans Genomic DNA in Human DNA Samples Extracted from Saliva and BloodAlexandre R Vieira, Kathleen B Deeley, Nicholas F Callahan, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|February 24, 2001
An alternative to synthetic aortic grafts using jejunumS E Marshall, S M Tweedt, C H Greene, et al.
The Journal of Frailty & Aging|February 12, 2021
Towards a Large-Scale Assessment of the Relationship between Biological and Chronological Aging: The INSPIRE Mouse CohortY Santin, S Lopez, I Ader, et al.
MMWR. Morbidity and Mortality Weekly Report|March 29, 2019
Enterovirus D68-Associated Acute Respiratory Illness - New Vaccine Surveillance Network, United States, July-October, 2017 and 2018Stephanie A Kujawski, Claire M Midgley, Brian Rha, et al.
Micropublication Biology|April 10, 2024
Pavement ant extract is a chemotaxis repellent for C. elegansJayela S Lopez, Saif Ali, Malcom Asher, et al.
Cancer Discovery|June 14, 2020
Phase I Trial of the PARP Inhibitor Olaparib and AKT Inhibitor Capivasertib in Patients with <i>BRCA1/2</i>- and Non-<i>BRCA1/2</i>-Mutant CancersTimothy A Yap, Rebecca Kristeleit, Vasiliki Michalarea, et al.
Journal of Environmental Management|June 1, 2019
Supporting the improvement of air quality management practices: The "FAIRMODE pilot" activityE Pisoni, C Guerreiro, S Lopez-Aparicio, et al.
Neurology|June 20, 2020
Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorderJohn J Chen, Eoin P Flanagan, M Tariq Bhatti, et al.
Pageof 79

Showing results (761-770 of 785) with videos related to

Sort By:
Pageof 79
Cancer Discovery|September 22, 2020
Triplet Therapy with Palbociclib, Taselisib, and Fulvestrant in <i>PIK3CA</i>-Mutant Breast Cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid CancersJavier Pascual, Joline S J Lim, Iain R Macpherson, et al.
Nature|January 22, 2025
Regional and institutional trends in assessment for academic promotionB H Lim, C D'Ippoliti, M Dominik, et al.
ISRN Dentistry|July 7, 2011
Detection of Streptococcus mutans Genomic DNA in Human DNA Samples Extracted from Saliva and BloodAlexandre R Vieira, Kathleen B Deeley, Nicholas F Callahan, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|February 24, 2001
An alternative to synthetic aortic grafts using jejunumS E Marshall, S M Tweedt, C H Greene, et al.
The Journal of Frailty & Aging|February 12, 2021
Towards a Large-Scale Assessment of the Relationship between Biological and Chronological Aging: The INSPIRE Mouse CohortY Santin, S Lopez, I Ader, et al.
MMWR. Morbidity and Mortality Weekly Report|March 29, 2019
Enterovirus D68-Associated Acute Respiratory Illness - New Vaccine Surveillance Network, United States, July-October, 2017 and 2018Stephanie A Kujawski, Claire M Midgley, Brian Rha, et al.
Micropublication Biology|April 10, 2024
Pavement ant extract is a chemotaxis repellent for C. elegansJayela S Lopez, Saif Ali, Malcom Asher, et al.
Cancer Discovery|June 14, 2020
Phase I Trial of the PARP Inhibitor Olaparib and AKT Inhibitor Capivasertib in Patients with <i>BRCA1/2</i>- and Non-<i>BRCA1/2</i>-Mutant CancersTimothy A Yap, Rebecca Kristeleit, Vasiliki Michalarea, et al.
Journal of Environmental Management|June 1, 2019
Supporting the improvement of air quality management practices: The "FAIRMODE pilot" activityE Pisoni, C Guerreiro, S Lopez-Aparicio, et al.
Neurology|June 20, 2020
Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorderJohn J Chen, Eoin P Flanagan, M Tariq Bhatti, et al.
Pageof 79